(S (NP-SBJ (NP (DT A) (JJ novel) (JJ Ets-related) (NN transcription) (NN factor)) (, ,) (NP (NN Elf-1)) (, ,)) (VP (VBZ binds) (PP (TO to) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 2) (JJ regulatory) (NNS elements)) (SBAR (WHNP-11 (WDT that)) (S (NP-SBJ-12 (-NONE- *T*-11)) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-12)) (PP (IN for) (NP (NP (JJ inducible) (JJ trans) (NN activation)) (PP (IN in) (NP (NN T) (NNS cells)))))))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (JJ Human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (CC and) (NP (NN HIV-2))) (VP (VBP are) (NP-PRD (NP (ADJP (RB structurally) (JJ related)) (NNS retroviruses)) (SBAR (WHNP-13 (WDT which)) (S (NP-SBJ (NP (-NONE- *T*-13))) (VP (DT both) (VP (VBP cause) (NP (NN AIDS)) (PP (IN in) (NP (NNS humans))))))))) (. .))
(S (SBAR-ADV (IN Although) (S (NP-SBJ (DT both) (NNS viruses)) (VP (VBP establish) (NP (NN latency)) (PP (IN in) (NP (JJ quiescent) (JJ human-peripheral-blood) (NN T) (NNS cells)))))) (, ,) (NP-SBJ (NP (DT the) (JJ asymptomatic) (NN phase)) (PP (IN of) (NP (NN HIV-2) (NN infection)))) (VP (MD may) (VP (VB be) (ADJP-PRD (ADJP (JJR more) (JJ prolonged)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NN HIV-1)))))))) (. .))
(S (NP-SBJ-14 (NP (DT The) (JJ latent) (NNS phases)) (PP (IN of) (NP (NP-COOD (CC both) (NP (NN HIV-1)) (CC and) (NP (NN HIV-2))) (NN infection)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-15 (-NONE- *-14)) (VP (TO to) (VP (VB be) (VP (VP (VBN disrupted) (NP (-NONE- *-15)) (PP (IN by) (NP-LGS (NN T-cell) (NN activation)))) (, ,) (NP (NP (DT a) (NN process)) (SBAR (WHNP-16 (WDT that)) (S (NP-SBJ (-NONE- *T*-16)) (VP (VBZ requires) (NP (NN host) (NN cell) (NN transcription) (NNS factors))))))))))))) (. .))
(S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN HIV-1))))) (, ,) (NP-SBJ (DT the) (NN transcription) (NN factor) (NN NF-kappa) (NN B)) (VP (VBZ is) (ADJP-PRD (JJ sufficient) (PP (IN for) (NP (JJ inducible) (JJ transcriptional) (NN activation))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-17 (NP (NNS factors)) (PP (IN in) (NN addition) (TO to) (NP (NN NF-kappa) (NN B)))) (VP (VBP are) (VP (VBN required) (S (NP-SBJ (-NONE- *-17)) (VP (TO to) (VP (VB activate) (NP (NN HIV-2) (NN transcription)) (PP (IN in) (NP (JJ infected) (NN T) (NNS cells)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ novel) (JJ Ets-related) (NN transcription) (NN factor)) (, ,) (NP (NN Elf-1)) (, ,)) (VP (VBZ binds) (ADVP (RB specifically)) (PP (TO to) (NP (NP (CD two) (JJ purine-rich) (NNS motifs)) (PP (IN in) (NP (DT the) (NN HIV-2) (NN enhancer))))))))) (. .))
(S (NP-SBJ (NN Mutagenesis) (NNS experiments)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-19 (DT these) (NN Elf-1) (NN binding) (NNS sites)) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-19)) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (NN HIV-2) (NN transcription))) (PP-TMP (VBG following) (NP (JJ T-cell-receptor-mediated) (NN T-cell) (NN activation)))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NN Elf-1)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ only) (NN factor)) (ADJP (JJ present) (PP (IN in) (NP (NP (VBN activated) (NN T-cell) (JJ nuclear) (NNS extracts)) (SBAR (WHNP-20 (WDT that)) (S (NP-SBJ (-NONE- *T*-20)) (VP (VBZ binds) (PP (TO to) (NP (DT these) (NNS sites))) (PP (IN in) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN Elf-1)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ novel) (NN transcription) (NN factor)) (SBAR (WHNP-21 (WDT that)) (S (NP-SBJ-22 (-NONE- *T*-21)) (VP (VBZ appears) (S (NP-SBJ-23 (-NONE- *-22)) (VP (TO to) (VP (VB be) (VP (VBN required) (NP (-NONE- *-23)) (PP (IN for) (NP (NP (DT the) (JJ T-cell-receptor-mediated) (JJ trans) (NN activation)) (PP (IN of) (NP (NN HIV-2) (NN gene) (NN expression)))))))))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP-COOD (VP (MD may) (VP (VB explain) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NNS spectra)) (PP (IN of) (NP (NP (NNS diseases)) (VP (VBN caused) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (NN HIV-1)) (CC and) (NP (NN HIV-2)))))))))))) (CC and) (VP (MD may) (ADVP (RB also)) (VP (VB have) (NP (NP (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN design)) (PP (IN of) (NP (NP (JJ therapeutic) (NNS approaches)) (PP (TO to) (NP (NN HIV-2) (NN infection))))))))))) (. .))
